Assessment and topographic characterization of locoregional recurrences in head and neck tumours

Radiation Oncology

Maria do Carmo Lopes¹  Pedro Sá-Couto²  Tânia Santos³  Leila Khouri⁴  Rui Vale Marques⁴  Brigida Costa Ferreira⁵ 

[1] Medical Physics Department, Portuguese Oncology Institute of Coimbra Francisco Gentil, Coimbra, Portugal;Center for Research and Development in Mathematics and Applications and Department of Mathematics, Aveiro University, Aveiro, Portugal;Physics Department, Coimbra University, Coimbra, Portugal;Radiation Therapy Department, Portuguese Oncology Institute of Coimbra Francisco Gentil (IPOCFG), Coimbra, Portugal;Serviço de Física Médica, Inst. Port. Oncology of Coimbra, Av. Bissaya Barreto 3000-075, Coimbra, Portugal

关键词: Dosimetric assessment;    Geometric methods;    Characterization of tumour recurrences;    Radiation therapy;    Head and neck tumours;   

Others  :  1149666
DOI  :  10.1186/s13014-015-0345-4

 received in 2014-06-16, accepted in 2015-02-01,  发布年份 2015

【 摘 要 】

Purpose

To evaluate the differences between three methods of classification of recurrences in patients with head and neck tumours treated with Radiation Therapy (RT).

Materials and methods

367 patients with head and neck tumours were included in the study. Tumour recurrences were delineated in the CT images taken during patient follow-up and deformable registration was used to transfer this volume into the planning CT. The methods used to classify recurrences were: method CTV quantified the intersection volume between the recurrence and the Clinical Target Volume (CTV); method TV quantified the intersection between the Treated Volume and the recurrence (for method CTV and TV, recurrences were classified in-field if more than 95% of their volume were inside the volume of interest, marginal if the intersection was between 20-95% and outfield otherwise); and method COM was based on the position of the Centre Of Mass of the recurrence. A dose assessment in the recurrence volume was also made.

Results

The 2-year Kaplan-Meier locoregional recurrence incidence was 10%. Tumour recurrences occurred in 22 patients in a mean time of 16.5 ± 9.4 months resulting in 28 recurrence volumes. The percentage of in-field recurrences for methods CTV, TV and COM was 7%, 43% and 50%, respectively. Agreement between the three methods in characterizing individually in-field and marginal recurrences was found only in six cases. Methods CTV and COM agreed in 14. The percentage of outfield recurrences was 29% using all methods. For local recurrences (in-field or marginal to gross disease) the average difference between the prescribed dose and D_98% in the recurrence volume was -5.2 ± 3.5% (range: -10.1%-0.9%).

Conclusions

The classification of in-field and marginal recurrences is very dependent on the method used to characterize recurrences. Using methods TV and COM the largest percentage of tumour recurrences occurred in-field in tissues irradiated with high doses.

【 授权许可】

   
2015 Ferreira et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011; 80(3):661-8.
• [2]Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C et al.. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011; 12(2):127-36.
• [3]Toledano I, Graff P, Serre A, Boisselier P, Bensadoun RJ, Ortholan C et al.. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol. 2012; 103(1):57-62.
• [4]Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008; 70(3):660-5.
• [5]Gupta T, Jain S, Agarwal JP, Ghosh-Laskar S, Phurailatpam R, Pai-Shetty R et al.. Prospective assessment of patterns of failure after high-precision definitive (chemo)radiation in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2011; 80(2):522-31.
• [6]Chajon E, Lafond C, Louvel G, Castelli J, Williaume D, Henry O et al.. Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control. Radiat Oncol. 2013; 8(1):132. BioMed Central Full Text
• [7]Raktoe SA, Dehnad H, Raaijmakers CP, Braunius W, Terhaard CH. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2013; 85(1):136-41.
• [8]Shakam A, Scrimger R, Liu D, Mohamed M, Parliament M, Field GC et al.. Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial. Radiother Oncol. 2011; 99(2):101-7.
• [9]Yang H, Hu W, Wang W, Chen P, Ding W, Luo W. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013; 85(1):47-54.
• [10]Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA et al.. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000; 46(5):1117-26.
• [11]Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003; 55(2):312-21.
• [12]Grégoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V et al.. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003; 69(3):227-36.
• [13]Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006; 79(1):15-20.
• [14]Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999; 45(3):577-87.
• [15]Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy. ICRU Publications, Bethesda; 2010.
• [16]Ferreira BC, Lopes MC, Mateus J, Capela M, Mavroidis P. Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours. Radiat Oncol. 2010; 5:57. BioMed Central Full Text
• [17]Wang J, Bai S, Chen N, Xu F, Jiang X, Li Y et al.. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol. 2009; 90(2):221-7.
• [18]Lopes MC, Ferreira BC, Mateus J, Ventura T. Deformable image registration for radiation therapy planning using Velocity AI software. Radiother Oncol. 2013; 106(S2):S483.
• [19]Prescribing, recording, and reporting photon beam therapy, 50. ICRU Publications, Bethesda, MD; 1994.